JPY 1074.0
(0.09%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 171.84 Million JPY | 18.57% |
2022 | -92.22 Million JPY | -72.45% |
2021 | 329.61 Million JPY | 283.96% |
2020 | -345.64 Million JPY | -954.59% |
2019 | -328.98 Million JPY | -94.42% |
2018 | 593.24 Million JPY | -31.88% |
2017 | 857.22 Million JPY | -77.21% |
2016 | 575.66 Million JPY | 73.26% |
2015 | 616.32 Million JPY | -13.08% |
2014 | 961.17 Million JPY | -21.6% |
2013 | 1.73 Billion JPY | 55.39% |
2012 | 1.18 Billion JPY | -49.2% |
2011 | 2.5 Billion JPY | 61.69% |
2010 | 1.54 Billion JPY | 1.48% |
2009 | 1.72 Billion JPY | 2.01% |
2008 | 1.43 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -50.5 Million JPY | -444.36% |
2023 Q1 | -1.02 Million JPY | 97.51% |
2023 Q4 | 14.66 Million JPY | 173.34% |
2023 Q2 | 113.58 Million JPY | 11181.27% |
2023 Q3 | -19.99 Million JPY | -117.61% |
2023 FY | - JPY | 18.57% |
2022 Q3 | -33.71 Million JPY | 15.63% |
2022 Q4 | -41.18 Million JPY | -22.15% |
2022 Q1 | -11.84 Million JPY | 66.22% |
2022 Q2 | -39.96 Million JPY | -237.41% |
2022 FY | - JPY | -72.45% |
2021 Q2 | 142.63 Million JPY | 193.87% |
2021 Q1 | 48.53 Million JPY | 312.56% |
2021 FY | - JPY | 283.96% |
2021 Q3 | 145.55 Million JPY | 2.05% |
2021 Q4 | -35.06 Million JPY | -124.09% |
2020 Q1 | -713.23 Million JPY | -281.61% |
2020 FY | - JPY | -954.59% |
2020 Q4 | -22.83 Million JPY | -123.96% |
2020 Q3 | 95.28 Million JPY | -27.31% |
2020 Q2 | 131.07 Million JPY | 118.38% |
2019 Q2 | 214.09 Million JPY | 675.53% |
2019 FY | - JPY | -94.42% |
2019 Q1 | -37.19 Million JPY | -120.16% |
2019 Q3 | -259.92 Million JPY | -221.41% |
2019 Q4 | -186.9 Million JPY | 28.09% |
2018 FY | - JPY | -31.88% |
2018 Q4 | 184.49 Million JPY | 95.19% |
2018 Q3 | 94.52 Million JPY | -36.81% |
2018 Q2 | 149.58 Million JPY | -12.28% |
2018 Q1 | 170.53 Million JPY | 102.04% |
2017 Q1 | 3.14 Billion JPY | 157.96% |
2017 FY | - JPY | -77.21% |
2017 Q3 | 3.09 Billion JPY | 3.49% |
2017 Q4 | -8.36 Billion JPY | -369.92% |
2017 Q2 | 2.99 Billion JPY | -4.97% |
2016 Q4 | -5.43 Billion JPY | -269.17% |
2016 FY | - JPY | 73.26% |
2016 Q3 | 3.21 Billion JPY | 7.19% |
2016 Q2 | 2.99 Billion JPY | -2.89% |
2016 Q1 | 3.08 Billion JPY | 212.74% |
2015 Q4 | -2.73 Billion JPY | -251.57% |
2015 Q3 | 1.8 Billion JPY | 13.14% |
2015 Q2 | 1.59 Billion JPY | 2.1% |
2015 Q1 | 1.56 Billion JPY | 151.28% |
2015 FY | - JPY | -13.08% |
2014 Q4 | -3.04 Billion JPY | -250.93% |
2014 Q2 | 1.87 Billion JPY | 9.55% |
2014 Q1 | 1.71 Billion JPY | 160.02% |
2014 Q3 | 2.01 Billion JPY | 7.56% |
2014 FY | - JPY | -21.6% |
2013 Q4 | -2.85 Billion JPY | -242.64% |
2013 Q1 | 2.06 Billion JPY | 157.81% |
2013 Q2 | 2.05 Billion JPY | -0.58% |
2013 Q3 | 2 Billion JPY | -2.6% |
2013 FY | - JPY | 55.39% |
2012 Q2 | 1.87 Billion JPY | -3.62% |
2012 Q1 | 1.94 Billion JPY | 128.24% |
2012 Q3 | 1.85 Billion JPY | -0.99% |
2012 Q4 | -3.57 Billion JPY | -292.53% |
2012 FY | - JPY | -49.2% |
2011 Q3 | 3.52 Billion JPY | 4.64% |
2011 Q1 | 4.14 Billion JPY | 219.15% |
2011 Q2 | 3.36 Billion JPY | -18.85% |
2011 FY | - JPY | 61.69% |
2011 Q4 | -6.89 Billion JPY | -295.72% |
2010 Q1 | 2.13 Billion JPY | 165.31% |
2010 Q2 | 2.04 Billion JPY | -4.41% |
2010 Q3 | 3.39 Billion JPY | 66.19% |
2010 FY | - JPY | 1.48% |
2010 Q4 | -3.48 Billion JPY | -202.6% |
2009 FY | - JPY | 2.01% |
2009 Q1 | 1.96 Billion JPY | 0.0% |
2009 Q2 | 1.75 Billion JPY | -10.98% |
2009 Q4 | -3.27 Billion JPY | -257.87% |
2009 Q3 | 2.07 Billion JPY | 18.14% |
2008 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | 89.178% |
Euglena Co., Ltd. | 676 Million JPY | 74.579% |
BEAUTY GARAGE Inc. | 1.96 Billion JPY | 91.254% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | 69.079% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | 95.718% |
Kao Corporation | 154.49 Billion JPY | 99.889% |
Niitaka Co., Ltd. | 1.36 Billion JPY | 87.452% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 99.648% |
Shiseido Company, Limited | 106.46 Billion JPY | 99.839% |
Lion Corporation | 42.31 Billion JPY | 99.594% |
Mandom Corporation | 6.69 Billion JPY | 97.435% |
Ivy Cosmetics Corporation | 242.6 Million JPY | 29.164% |
Milbon Co., Ltd. | 7.8 Billion JPY | 97.797% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | 86.664% |
Fancl Corporation | 16.6 Billion JPY | 98.965% |
KOSÉ Corporation | 26.85 Billion JPY | 99.36% |
Cota Co., Ltd. | 2.26 Billion JPY | 92.425% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 113.075% |
Pola Orbis Holdings Inc. | 23.17 Billion JPY | 99.259% |
Noevir Holdings Co., Ltd. | 12.24 Billion JPY | 98.596% |
Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -38.586% |
Almado, Inc. | 983.21 Million JPY | 82.522% |
I-ne CO., LTD. | 4.7 Billion JPY | 96.344% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 127.408% |
Liberta Co.,Ltd. | 318.19 Million JPY | 45.993% |
AXXZIA Inc. | 1.28 Billion JPY | 86.642% |
S.T. Corporation | 2.62 Billion JPY | 93.456% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 99.458% |
Earth Corporation | 10.6 Billion JPY | 98.38% |
Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | 84.3% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 129.939% |
Ya-Man Ltd. | 1.43 Billion JPY | 88.039% |
MTG Co., Ltd. | 4.39 Billion JPY | 96.089% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | 97.042% |
SHOBIDO Corporation | 1.11 Billion JPY | 84.521% |
Artnature Inc. | 3.78 Billion JPY | 95.462% |
Pigeon Corporation | 15.8 Billion JPY | 98.913% |
Unicharm Corporation | 178.01 Billion JPY | 99.903% |
Paltac Corporation | 35.92 Billion JPY | 99.522% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | 94.769% |